Tramadol carries real risks for older adults, though it is generally safer than stronger opioids. It sits in a middle ground: fewer serious side effects than more potent painkillers, but consistently more adverse events than taking no opioid at all. The American Geriatrics Society lists tramadol as a medication to “use with caution” in older adults, not one to avoid entirely. Whether it’s the right choice depends on what other medications are in the mix, how well the kidneys are working, and how carefully side effects are monitored.
How Tramadol Compares to Other Pain Options
Tramadol is often positioned as a gentler alternative to stronger opioids like oxycodone or morphine, and the data broadly supports that framing. In studies of older adults with osteoarthritis, tramadol users had lower rates of adverse events than people on other opioids across nearly every category: fewer emergency room visits, fewer hospitalizations, and lower risk of respiratory problems. It also doesn’t cause the kidney damage or stomach ulcers that make long-term use of anti-inflammatory drugs like ibuprofen or naproxen dangerous for older adults.
But “safer than stronger opioids” is not the same as “safe.” Compared to older adults not taking any opioid, tramadol users were about 50% more likely to experience a fall or fracture, roughly 40% more likely to be hospitalized for a cardiovascular event, and 35% more likely to be hospitalized for any safety-related event. Over a 33-month period, about 25% of tramadol users experienced a fall or hip fracture, compared to 16% of non-users. Those aren’t small differences.
Tramadol also causes gastrointestinal side effects at high rates. In one study of older adults taking tramadol combined with acetaminophen, 54% experienced nausea or vomiting and 46% had constipation. These side effects are similar in severity to what stronger opioids cause, even though tramadol is considered a lower-tier option. Dizziness and headaches are also common.
Falls and Hip Fractures
Fall risk is one of the most important concerns for any medication prescribed to someone over 60. Tramadol causes dizziness, sedation, and impaired thinking, all of which make falls more likely. Research on older adults with osteoarthritis found that tramadol use raised the risk of hip fracture by 41%. The risk was sharpest in people aged 60 to 70, where it more than doubled, and in men, where it increased by 83%.
Long-term use appears to be the key factor. Studies looking at people who took tramadol for at least 90 continuous days within a year found that cumulative hip fracture rates reached 24.2%, compared to 13.5% in a matched group not taking tramadol. If you or a family member is taking tramadol regularly, fall-prevention measures like removing tripping hazards, using grab bars, and avoiding getting up too quickly become especially important.
The First Few Weeks Are the Riskiest
People who are new to tramadol face higher risks than those who have been taking it for a while. New users had a 59% increased risk of falls and fractures compared to non-users, while continuing users had a 48% increase. The same pattern held for cardiovascular hospitalizations and emergency room visits. This likely reflects both the body’s initial adjustment period and the fact that people who tolerate the drug poorly tend to stop taking it early, leaving a group of continuing users who handle it better.
The practical takeaway: the first several weeks after starting tramadol deserve extra caution. Watch for unusual dizziness, confusion, or unsteadiness, and be especially careful with activities like driving or using stairs.
Serotonin Syndrome and Drug Interactions
Tramadol doesn’t just work on opioid receptors. It also increases levels of serotonin in the brain, which creates a specific and serious risk when combined with antidepressants. Many older adults take SSRIs (like citalopram or sertraline) or SNRIs (like venlafaxine or duloxetine) for depression or anxiety. Adding tramadol on top of these medications can push serotonin levels dangerously high, triggering a condition called serotonin syndrome.
Serotonin syndrome can cause tremors, confusion, hallucinations, rapid heart rate, fever, and sweating. In one documented case, a 79-year-old woman who was already taking citalopram and trazodone for depression developed generalized weakness, tremors, hallucinations, fever, and rapid breathing within days of starting tramadol. The FDA specifically warns about this combination, and it’s one of the most important things to flag if a prescriber suggests tramadol for someone already on an antidepressant. Sleep aids, tranquilizers, and other sedating medications also interact with tramadol and increase the risk of dangerous sedation.
Low Sodium Levels
A less well-known risk of tramadol is hyponatremia, a drop in blood sodium that can cause confusion, nausea, headaches, and in severe cases, seizures. Tramadol triggers this by increasing the release of a hormone that causes the kidneys to retain too much water, diluting sodium in the blood. The 2023 Beers Criteria from the American Geriatrics Society specifically flags this risk and recommends monitoring sodium levels when starting tramadol or changing the dose in older adults.
In a large real-world study of nearly 31,000 patients (39% of whom were over 65), 8.4% of those taking tramadol with acetaminophen developed low sodium within 10 days, compared to 4.2% taking acetaminophen alone. Extended-release formulations carried a higher risk than immediate-release versions. Because the symptoms of low sodium (confusion, fatigue, unsteadiness) overlap with symptoms people might attribute to aging or the pain itself, it can easily go unrecognized.
Seizure Risk
Tramadol lowers the seizure threshold, meaning it makes seizures more likely to occur. This risk increases when tramadol is taken alongside antidepressants, at high doses, or in people who already have a seizure disorder. The FDA includes seizures among its listed warnings for the drug. While seizures from tramadol are not common, they represent a potentially dangerous event for an older person, and the risk compounds when tramadol is combined with other medications that also affect brain chemistry.
Dose Limits for Older Adults
The body processes tramadol more slowly with age. In people over 75, the drug takes longer to clear from the system, which means it builds up more easily and side effects become more likely. The FDA recommends that adults over 75 take no more than 300 mg per day. For anyone with significant kidney impairment (creatinine clearance below 30 mL/min), the dosing interval should be stretched to every 12 hours with a daily maximum of 200 mg, and extended-release formulations should be avoided entirely.
Starting low and increasing slowly is the standard approach for prescribing tramadol to older adults, reflecting the higher likelihood of reduced kidney, liver, or heart function and the greater chance of interactions with other medications.
Stopping Tramadol Safely
If you’ve been taking tramadol regularly for more than a few weeks, stopping suddenly can cause withdrawal symptoms including anxiety, sweating, insomnia, tremors, and a rebound in pain. The FDA warns that abrupt discontinuation of opioids, including tramadol, has been linked to serious withdrawal, uncontrolled pain, and psychological distress.
There is no one-size-fits-all tapering schedule. The general guideline is to reduce the dose by no more than 10% to 25% every two to four weeks, adjusted based on how long you’ve been taking it and how your body responds. This process should be planned and gradual, not something done on your own by skipping doses or cutting pills.
Who Should Be Most Cautious
Tramadol’s risks are highest in older adults who take antidepressants or other serotonin-affecting medications, have a history of falls or osteoporosis, have reduced kidney function, take sedatives or sleep medications, or are over 75. For someone with none of these risk factors who needs pain relief beyond what acetaminophen alone can provide, tramadol may be a reasonable option with appropriate monitoring. For someone with several of these factors, the risks can stack up quickly, and the conversation with a prescriber should weigh those carefully against the benefit of pain control.